Results 1 to 10 of about 1,316,517 (248)

Activating BRAF mutation in sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: two case reports and review of the literature

open access: yesJournal of Medical Case Reports, 2019
Background Sclerosing mucoepidermoid carcinoma with eosinophilia is a rare form of thyroid carcinoma. The underlying molecular mechanisms of sclerosing mucoepidermoid carcinoma with eosinophilia tumorigenesis remain unknown.
Jasmine S. Sukumar   +6 more
doaj   +2 more sources

Infarcted Warthin tumor with mucoepidermoid carcinoma-like metaplasia: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2019
Background Warthin tumor is a common, benign, painless salivary gland neoplasm. Rarely, Warthin tumors show large areas of squamous metaplasia; such Warthin tumors are called metaplastic or infarcted Warthin tumors because they are occasionally ...
Kenji Yorita   +5 more
doaj   +2 more sources

Mucoepidermoid carcinoma of the base of the tongue: a case report and review of the literature [PDF]

open access: yesJournal of Medical Case Reports
Background Mucoepidermoid carcinoma originates from reserve cells present in ducts of salivary glands and is the most common malignancy of the salivary glands. It is commonly found in the parotid gland, followed by the palatal and buccal mucous membranes.
Peng Wang   +4 more
doaj   +2 more sources

Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Protein phosphatase 2A (PP2A) is a ubiquitous serine/threonine phosphatase that mediates cell cycle regulation and metabolism. Mounting evidence has indicated that PP2A inhibition exhibits considerable anticancer potency in multiple ...
Limin Liu   +13 more
doaj   +2 more sources

Primary mucoepidermoid carcinoma of scalp: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Mucoepidermoid carcinoma of the skin is an exceedingly rare neoplasm, with only a limited number of cases documented in the literature.
Jay Lodhia   +7 more
doaj   +2 more sources

Nasopharyngeal mucoepidermoid carcinoma with mastermind-like transcriptional coactivator 2 translocation: A case report and comprehensive literature review of a rare entity [PDF]

open access: yesSAGE Open Medical Case Reports
Mucoepidermoid carcinoma is one of the most common malignant tumors in salivary glands and is usually associated with mastermind-like transcriptional coactivator 2 (MAML2) rearrangement.
Chan-Fong Chio   +6 more
doaj   +2 more sources

Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia: a case report and review of the literature [PDF]

open access: yesJournal of Medical Case Reports
Background Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia (SMECE) is a rare thyroid tumor. More and more reports have proposed that sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia is significantly invasive, but ...
Qianqian Han, Huan Xu
doaj   +2 more sources

Central mucoepidermoid carcinoma of the mandible

open access: yesIndian Journal of Dental Research, 2010
Central mucoepidermoid carcinoma are extremely rare tumors, representing about 2 to 4% of all mucoepidermoid carcinomas. They are histologically low-grade cancers, usually affecting the mandible as uni- or multilocular radiographic lesions ...
Munde Anita   +3 more
doaj   +3 more sources

Mucoepidermoid carcinoma [PDF]

open access: yesBMJ Case Reports, 2014
Salivary gland tumours comprise almost 5% of head and neck malignancies. Minor salivary gland tumours account for 10–15% of all salivary gland neoplasms and are usually malignant. The second most common minor salivary gland tumour (12–40% globally) is mucoepidermoid carcinoma.
Ramlal Gantala   +3 more
openaire   +3 more sources

The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma

open access: yesJCI Insight, 2021
No effective systemic treatment is available for patients with unresectable, recurrent, or metastatic mucoepidermoid carcinoma (MEC), the most common salivary gland malignancy.
Zirong Chen   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy